PlantForm Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

PlantForm General Information

Description

Developer of biopharmaceutical products designed to assist in cancer treatment. The company utilizes plant-based expression technology to produce recombinant protein pharmaceuticals, including monoclonal antibodies, therapeutic proteins, and vaccines, enabling the biopharmaceutical market to develop cost-effective treatments for cancer and other life-threatening diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1920 Yonge Street
  • Suite 200
  • Toronto, Ontario M4S 3E2
  • Canada
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Other Agriculture
Biotechnology
Vertical(s)
Corporate Office
  • 1920 Yonge Street
  • Suite 200
  • Toronto, Ontario M4S 3E2
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PlantForm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Secondary Transaction - Private 01-May-2026 Completed Generating Revenue
15. Later Stage VC Cancelled Generating Revenue
14. Grant 27-Feb-2018 Completed Generating Revenue
13. Grant 12-Dec-2016 Completed Generating Revenue
12. Grant 04-Jan-2016 Completed Generating Revenue
11. Grant 28-Oct-2015 Completed Generating Revenue
10. Grant 31-Mar-2015 Completed Generating Revenue
9. Grant 22-Dec-2014 Completed Generating Revenue
8. Grant 16-May-2014 $20K $3.5M Completed Generating Revenue
7. Later Stage VC 20-Aug-2013 $2M $3.5M Completed Clinical Trials - Phase 1
To view PlantForm’s complete valuation and funding history, request access »

PlantForm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical products designed to assist in cancer treatment. The company utilizes plant-based express
Drug Discovery
Toronto, Canada
24 As of 2026

Cambridge, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PlantForm Competitors (19)

One of PlantForm’s 19 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
Abeona Therapeutics Corporation Cleveland, OH
You’re viewing 5 of 19 competitors. Get the full list »

PlantForm Patents

PlantForm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260049318-A1 Inhibition of plant protease aed3-1 for improved heterologous protein production Pending 13-Aug-2024
CA-3179142-A1 Production of ace2-fc fusion protein in plants and uses thereof Pending 13-Oct-2021
US-20250122518-A1 T-dna vector encoding a post-translational modification enzyme and lacking regulatory sequences for its expression Pending 06-Mar-2019
US-20250122519-A1 T-dna vector encoding a post-translational modification enzyme and lacking regulatory sequences for its expression Pending 06-Mar-2019
CA-3132423-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 C12N15/8257
To view PlantForm’s complete patent history, request access »

PlantForm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PlantForm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlantic Assets Trust Corporation Minority
To view PlantForm’s complete investors history, request access »

PlantForm Investments (1)

PlantForm’s most recent deal was a Joint Venture with PlantPraxis. The deal was made on 01-Jan-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PlantPraxis 01-Jan-2014 Joint Venture Pharmaceuticals
To view PlantForm’s complete investments history, request access »

PlantForm FAQs

  • When was PlantForm founded?

    PlantForm was founded in 2008.

  • Where is PlantForm headquartered?

    PlantForm is headquartered in Toronto, Canada.

  • What is the size of PlantForm?

    PlantForm has 24 total employees.

  • What industry is PlantForm in?

    PlantForm’s primary industry is Drug Discovery.

  • Is PlantForm a private or public company?

    PlantForm is a Private company.

  • What is PlantForm’s current revenue?

    The current revenue for PlantForm is .

  • How much funding has PlantForm raised over time?

    PlantForm has raised $3.5M.

  • Who are PlantForm’s investors?

    Atlantic Assets Trust has invested in PlantForm.

  • Who are PlantForm’s competitors?

    Vedanta Biosciences, Intellia Therapeutics, Vertex Pharmaceuticals, CRISPR Therapeutics, and Abeona Therapeutics are some of the 19 competitors of PlantForm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process